2005
DOI: 10.1016/j.taap.2005.03.001
|View full text |Cite
|
Sign up to set email alerts
|

Arsenite induces endothelial cytotoxicity by down-regulation of vascular endothelial nitric oxide synthase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
22
0

Year Published

2006
2006
2015
2015

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 59 publications
(26 citation statements)
references
References 40 publications
2
22
0
Order By: Relevance
“…According to Tsou et al [21], eNOS from porcine aortic endothelial cells presents a dose-and timedependent decrease of activity and expression in presence of arsenite in the micromolar range. They proposed that arsenite decreases NO production by increasing eNOS degradation through the ubitiquinproteasome pathway and also through direct inhibition of eNOS activity, and the recent report by Kamada and collaborators [42] contributes to our understanding of NOS depletion associated with arsenic exposure.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…According to Tsou et al [21], eNOS from porcine aortic endothelial cells presents a dose-and timedependent decrease of activity and expression in presence of arsenite in the micromolar range. They proposed that arsenite decreases NO production by increasing eNOS degradation through the ubitiquinproteasome pathway and also through direct inhibition of eNOS activity, and the recent report by Kamada and collaborators [42] contributes to our understanding of NOS depletion associated with arsenic exposure.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, the involvement of nitric oxide (NO) in arsenic toxicity has raised considerable interest, and it is the subject of numerous current studies in humans [17,18], animal models [19,20] and in vitro preparations [21]. Furthermore, nitrergic dysfunction can also be linked to oxidative stress, since inadequate levels of tetrahydrobiopterin, one of the cofactors for NO synthesis are thought to contribute to superoxide formation by nitric oxide synthase (NOS) [22,23].…”
Section: Introductionmentioning
confidence: 99%
“…In addition to the direct action of ROS on NO, As inhibits endothelial NO synthetasis (eNOS) (Fig. 1) (Lee et al 2003;Tsou et al 2005;Li et al 2007), it depletes GSH -one of the main antioxidant ROS scavengers -and inhibits redox enzymes (catalase, glutathione peroxidase and reductase, thioredoxin reductase, superoxide dysmutase). The disruption of antioxidant defense mechanisms and the blocking of new NO formation further decrease NO bioavailability and increase endothelial dysfunction (Pi et al 2000).…”
Section: Endothelial Dysfunction: the Link Between As And CV Disease?mentioning
confidence: 99%
“…VE-cadherin can be degraded through several signal pathways, such as proteasome, caspase, matrix metalloproteinase (MMP), and lysosome proteases (24)(25)(26)(27). To determine which pathway might be involved, the effect of different inhibitors was compared.…”
Section: Overexpression Of Spliced Xbp1 Induces Ec Apoptosis Through mentioning
confidence: 99%